Physician
Nguyen, Hai
Nguyen, Hai was paid $3.64M by Medicaid between Jan 2018 and Dec 2024, across 95 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 50% of everything it billed.
33Billing provider infoNGUYEN, HAI
GRETNA, LA 70053
GRETNA, LA 70053
33aNPI1235295551assigned 12/29/2006
33bProvider typePediatrics Physician
28Total paid$3.64M
24GClaims211,141
24DCodes billed95
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Louisiana
Rank by total paid#41 of 230
Median peer was paid$429K
This provider vs. median8.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 33,617 | $522K | |
| 2019 | 43,967 | $766K | |
| 2020 | 44,652 | $748K | |
| 2021 | 44,396 | $876K | |
| 2022 | 30,756 | $578K | |
| 2023 | 8,845 | $102K | |
| 2024incomplete | 4,908 | $51K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 50% | 39,857 | 26,884 | $1.83M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 14% | 1,718 | 1,247 | $492K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 8.2% | 1,104 | 807 | $300K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.6% | 3,060 | 2,697 | $240K |
| 99051 | 2.8% | 7,768 | 5,913 | $103K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.5% | 3,541 | 2,753 | $92K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.4% | 4,291 | 3,692 | $86K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.7% | 952 | 849 | $63K |
| 99050 | 1.2% | 3,409 | 2,877 | $44K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.1% | 3,497 | 3,050 | $40K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,180 | 1,054 | $36K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,289 | 1,927 | $34K |
83 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,483 | $24K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,726 | $23K |
| 80305 | <1% | 3,680 | $21K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 936 | $16K |
| 94010 | <1% | 968 | $15K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,310 | $15K |
| 90686 | <1% | 1,400 | $14K | |
| 99415 | Prolong outpt/office vis | <1% | 3,347 | $13K |
| 87581 | <1% | 1,695 | $12K | |
| 87486 | <1% | 1,694 | $12K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,698 | $12K |
| 93000 | <1% | 1,228 | $12K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,462 | $12K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,452 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 329 | $9K |
| 82962 | <1% | 5,316 | $8K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 108 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,673 | $7K |
| 81025 | <1% | 1,124 | $6K | |
| 81002 | <1% | 3,267 | $5K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 101 | $5K |
| 72100 | <1% | 232 | $4K | |
| 90756 | <1% | 199 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 55 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 36 | $2K |
| 69210 | <1% | 97 | $2K | |
| 0011A | <1% | 81 | $2K | |
| 0012A | <1% | 66 | $1K | |
| 74019 | <1% | 58 | $1K | |
| 96127 | <1% | 180 | $795.73 | |
| 99354 | <1% | 443 | $661.87 | |
| 72040 | <1% | 26 | $559.68 | |
| 90688 | <1% | 381 | $364.39 | |
| 73562 | <1% | 18 | $344.96 | |
| 87634 | <1% | 17 | $339.98 | |
| 99454 | <1% | 108 | $231.93 | |
| 90715 | <1% | 36 | $216.27 | |
| 90620 | <1% | 63 | $210.00 | |
| 71045 | Radiologic examination, chest; single view | <1% | 16 | $182.26 |
| 99173 | <1% | 178 | $164.44 | |
| 99457 | <1% | 332 | $109.47 | |
| 99453 | <1% | 41 | $78.18 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 776 | $53.15 |
| 3074F | <1% | 6,218 | $14.50 | |
| 3078F | <1% | 5,182 | $11.50 | |
| 3075F | <1% | 2,870 | $5.50 | |
| 3079F | <1% | 4,124 | $5.50 | |
| 3080F | <1% | 5,241 | $3.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 40 | $1.48 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 86 | $0.45 |
| 4000F | 0% | 2,043 | $0.00 | |
| 3044F | 0% | 2,404 | $0.00 | |
| 1036F | 0% | 32,848 | $0.00 | |
| 99458 | 0% | 183 | $0.00 | |
| 3049F | 0% | 1,009 | $0.00 | |
| 1000F | 0% | 3,427 | $0.00 | |
| 1034F | 0% | 9,011 | $0.00 | |
| 90694 | 0% | 62 | $0.00 | |
| 3048F | 0% | 306 | $0.00 | |
| 3014F | 0% | 220 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 235 | $0.00 |
| 1170F | 0% | 14 | $0.00 | |
| 90698 | 0% | 13 | $0.00 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 20 | $0.00 |
| 91301 | 0% | 137 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 13 | $0.00 |
| 1111F | 0% | 48 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 12 | $0.00 |
| 1160F | 0% | 2,129 | $0.00 | |
| 3050F | 0% | 839 | $0.00 | |
| 3077F | 0% | 5,430 | $0.00 | |
| 1159F | 0% | 2,130 | $0.00 | |
| 90633 | 0% | 17 | $0.00 | |
| 90653 | 0% | 136 | $0.00 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 0% | 28 | $0.00 |
| 3051F | 0% | 22 | $0.00 | |
| 90713 | 0% | 14 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 338 | $0.00 |
| 90658 | 0% | 28 | $0.00 | |
| 90649 | 0% | 34 | $0.00 | |
| 90734 | 0% | 65 | $0.00 | |
| 90700 | 0% | 41 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.